Interferon α activates the tyrosine kinase Lyn in haemopoietic cells

被引:12
|
作者
Uddin, S
Grumbach, IM
Yi, TL
Colamonici, OR
Platanias, LC
机构
[1] Univ Illinois, Hematol Oncol Sect, Dept Med, Chicago, IL 60607 USA
[2] W Side Vet Affairs Hosp, Chicago, IL USA
[3] Cleveland Clin Fdn, Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA
[4] Univ Tennessee, Dept Pathol, Memphis, TN USA
关键词
interferon; tyrosine kinases; signal transduction;
D O I
10.1046/j.1365-2141.1998.00731.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated whether the src-family tyrosine kinase Lyn is involved in the generation of interferon alpha (IFN alpha) signals in haemopoietic cells. In vitro kinase assays using IFN alpha-sensitive cells of B-cell origin demonstrated the presence of IFN alpha-dependent kinase activity in anti-Lyn immunoprecipitates. Further studies demonstrated that Lyn associates via its src homology 2 (SH2) domain with the Janus family tyrosine kinase Tyk-2. This interaction was IFN alpha-dependent and involved direct binding of the SH2 domain of Lyn to the IFN alpha-activated form of Tyk-2. Thus, during binding of IFN alpha to its receptor in malignant haemopoietic cells, Lyn is engaged in an IFN alpha-signalling pathway, probably downstream of Tyk-2.
引用
收藏
页码:446 / 449
页数:4
相关论文
共 50 条
  • [41] α-thrombin activates Akt via a nonreceptor tyrosine kinase in IIC9 cells
    Phillips-Mason, PJ
    Goel, R
    Baldassare, JJ
    [J]. CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS, 2002, 973 : 142 - 144
  • [42] Protein tyrosine kinase Lyn mediates apoptosis induced by topoisomerase II inhibitors in DT40 cells
    Maruo, A
    Oishi, I
    Sada, K
    Nomi, M
    Kurosaki, T
    Minami, Y
    Yamamura, H
    [J]. INTERNATIONAL IMMUNOLOGY, 1999, 11 (09) : 1371 - 1380
  • [43] Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis
    Contri, A
    Brunati, AM
    Trentin, L
    Cabrelle, A
    Miorin, M
    Cesaro, L
    Pinna, LA
    Zambello, R
    Semenzato, G
    Donella-Deana, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02): : 369 - 378
  • [44] Lyn tyrosine kinase is abnormally expressed in chronic lymphocytic leukemia tumor B cells and contributes to defective apoptosis
    Trentin, L
    Brunati, A
    Contri, A
    Frezzato, F
    Carraro, S
    Cabrelle, A
    Miorin, M
    Cesaro, L
    Frasson, M
    Biasiolo, G
    Pinna, L
    Zambello, R
    Maschio, N
    Donella-Deana, A
    Agostini, C
    Semenzato, G
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 87 - 88
  • [45] Sequential enzymatic down-regulation and degradation of the Lyn tyrosine kinase in erythropoietin-stimulated cells.
    Ingley, E
    Schneider, JR
    McCarthy, DJ
    Harder, KW
    Hibbs, ML
    Alexander, WS
    Hilton, DJ
    Klinken, SP
    [J]. BLOOD, 2004, 104 (11) : 595A - 596A
  • [46] Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells
    Tilbrook, PA
    Ingley, E
    Williams, JH
    Hibbs, ML
    Klinken, SP
    [J]. EMBO JOURNAL, 1997, 16 (07): : 1610 - 1619
  • [47] Role of acid/base homeostasis in the suppression of apoptosis in haemopoietic cells by v-Abl protein tyrosine kinase
    Chen, Q
    Benson, RSP
    Whetton, AD
    Brant, SR
    Donowitz, M
    Montrose, MH
    Dive, C
    Watson, AJM
    [J]. JOURNAL OF CELL SCIENCE, 1997, 110 : 379 - 387
  • [48] Erythropoietin-stimulated Raf-1 tyrosine phosphorylation is associated with the tyrosine kinase Lyn in J2E erythroleukemic cells
    Tilbrook, PA
    Colley, SM
    McCarthy, DJ
    Marais, R
    Klinken, SP
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 396 (01) : 128 - 132
  • [49] Expression of the tyrosine kinase Lyn during B cell receptor engagement and apoptosis
    Huck, S
    Zouali, M
    [J]. B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 122 - 123
  • [50] The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim
    Lazaro E. Aira
    Elodie Villa
    Pascal Colosetti
    Parvati Gamas
    Laurie Signetti
    Sandrine Obba
    Emma Proics
    Fabien Gautier
    Béatrice Bailly-Maitre
    Arnaud Jacquel
    Guillaume Robert
    Frédéric Luciano
    Philippe P. Juin
    Jean-Ehrland Ricci
    Patrick Auberger
    Sandrine Marchetti
    [J]. Oncogene, 2018, 37 : 2122 - 2136